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Abstract 
This paper explains a novel approach for knowledge discovery from data generated by 
Point of Care (POC) devices. A very important element of this type of knowledge 
extraction is that the POC generated data would never be identifiable, thereby 
protecting the rights and the anonymity of the individual, whilst still allowing for vital 
population-level evidence to be obtained. This paper also reveals a real-world 
implementation of the novel approach in a big data analytics system. Using Internet of 
Things (IoT) enabled POC devices and the big data analytics system, the data can be 
collected, stored, and analyzed in batch and real-time modes to provide a detailed 
picture of a healthcare system as well to identify high-risk populations and their 
locations. In addition, the system offers benefits to national health authorities in forms 
of optimized resource allocation (from allocating consumables to finding the best 
location for new labs) thus supports efficient and timely decision-making processes.  
 
Keywords: Point of Care; Big Data Analytics; Internet of Things; Global Health; 
Machine Generated Data; Machine Learning 
1 Introduction  
Diagnostic Point of Care (POC) devices are important tools in the battle against infectious 
diseases as well as other acute and chronic diseases. POC tests can usually run faster than 
conventional laboratory testing and need less equipment [1]–[3]. Combining the test results 
data (generated by POC) with patient demographic data results in a comprehensive dataset 
which can be used efficiently to extract fine-grained surveillance information at individual-
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level as well as at population-level.  With the availability of a comprehensive dataset, 
performing almost any sort of analytics is feasible. Recently various types of real-time 
health monitoring systems have revolutionized the collection, sharing, and utilizing of 
data for personalized healthcare. The availability of a comprehensive dataset, 
advancement in analytical methods and technologies, especially the use of mobile 
devices, has led to the concept of mHealth [4]–[6]. The Executive Board of WHO in 2016 
considered mHealth as an important resource for individual and public health services 
delivery, especially monitoring the health status of each patient. However, there are 
several barriers to using concepts like mHelath in low and middle-income countries.  
For myriad political, social, privacy, technical, and security issues, especially in low and 
middle-income countries [7], coupling demographic data at the individual level is very difficult 
(if not impossible) and needs legal and ethical approval at various levels [8], [9]. If 
demographic data are decoupled from test results, neither individual-level nor population-level 
information can be inferred from the test results. As an example, although access to mobile 
technologies has rapidly expanded in low and middle-income countries, unclear 
healthcare system responsibilities, unreliable infrastructure, and lack of consistent data 
challenge their implementation [10].  
The contribution of this research paper is a new type of knowledge discovery and 
extraction based on just machine generated data e.g. using IoT-enabled POC devices. In 
other words, this paper proposes a novel approach for extracting meaningful and 
valuable population-level insights using just POC generated data including test results, 
duration of the tests, the location of the devices, errors and warnings, and quality control 
parameters. A very important element of this type of knowledge extraction is that the 
POC generated data would never be identifiable, thereby protecting the rights and the 
anonymity of the individual, whilst still allowing for vital population-level evidence to be 
obtained. 
Along with this contribution, we also explain a rather sophisticated architecture for 
implementation of a big data solution to support the main contribution. The implemented 
system of this paper is capable of storing, processing and analyzing the vast amount of data in 
real-time and batch modes. This paper uncovers the potential of using big data analytics in 
the healthcare domain to find useful information in highly valuable (but untapped) POC 
generated data. As illustrated in the paper, the implemented system can also provide the POC 
data to external analytics clients for performing further knowledge extraction using visual 
analytics, spatial analytics, and advanced analytics.  
By using this novel approach, integration of data from heterogeneous POC devices (various 
devices which generate data in different data structures and encoding) is significantly less 
complex and time-consuming than existing approaches. In addition, real-time data collection 
and real-time analytics can be achieved using the approach of this research which supports 
efficient and timely decision-making processes. For example, the system described in this 
paper is capable of detecting anomalies automatically in real-time (without the need for human 
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intervention) to take appropriate actions using alerts and triggers (informing responsible people 
and/or authorities for example).  
In addition, the big data analytics system uses Internet of Things (IoT) enabled POC devices 
to automate data generation and storage. As is illustrated in the paper, the resulting system has 
real-world application for extracting valuable and useful information at a population-level from 
the machine-generated POC diagnostic and laboratory data. The paper has been organized as 
follows: Section 2 describes the importance of the POC devices. Then the technical 
requirements of POC are discussed in section 3. Section 4, illustrates the data that is generated 
by POC devices and then introduces the accessibility issue of the data generated by POC 
machines. The proposed solution, including the common data structure and data analytics, is 
explained in section 5. The big data architecture of the proposed solution, its implementation 
details and the benefits of it over existing approaches, are described in section 6 and 7 
respectively. Some important results of descriptive, diagnostics, predictive and prescriptive 
analytics of the system are illustrated in section 8 and, finally, section 9 concludes the paper 
by discussing proposed future directions for the research project.  
2 The Importance of POC 
The POC diagnostic tests are very important in the battle against infectious diseases as well as 
other acute and chronic diseases. POC tests can usually run faster than conventional laboratory 
testing, and with less equipment, so they can extend healthcare availability into the community 
and reduce the number of patients lost to follow-up (LTFU), or the number of treatments 
initiated too late [11]–[13]. This aspect of POC diagnostics tests is highly valuable for many 
high-burden infectious diseases such as HIV, TB, malaria and others, where earlier diagnosis 
and treatment can also mean the difference between life and death [14], [15]. Most studies have 
concluded that POC devices are suitable alternatives to traditional laboratory devices [11]. 
Accurate and timely diagnosis of patients has been a key aspect of the response to infectious 
diseases, especially measures to prevent onward transmission. In the recent Ebola outbreak, the 
process for differentiating those who have Ebola from those who do not has posed a great 
danger to patients. During the height of the epidemic, laboratory and surveillance professionals 
were overwhelmed, which often led to long wait times and caused the patients a great deal of 
anxiety [16]. Even after samples are collected, they had to be transported to a laboratory with 
the capacity to perform the complex and time-consuming tests required. In the case of Ebola, 
the time from sample collection to receipt of result reported to be greater than six days on 
average [17]. These delays present patients with an unbearable wait and, more importantly, put 
uninfected individuals at risk of being infected [18], as well as reducing the number of LTFU 
or the number of treatments initiated late [11]. In this case, the use of POC tests can mean that 
the tests can be done where the patients are [15]–[18]. In other words, POC devices can be used 
efficiently to reduce the delay between a patient’s arrival at the clinic and a confirmed 
diagnosis. In addition, it is sometimes possible to use portable (mobile) POC devices and, 
therefore, eliminate the need for transport of samples and more importantly it is possible to test 
patients closer to their community. This is very important since most of the population, 
especially in rural areas particularly in low and middle-income countries, are tested only when 
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they have access to a close healthcare services [1], [15]. The availability of POC (especially 
portable devices) can expand the reach of healthcare beyond what a conventional laboratory 
could do on its own. 
3 Technical Requirements of POC 
The WHO defined an ideal POC with ‘ASSURED’ characteristics, which stands for 
Affordability, Sensitivity, Specificity, User-friendliness, Rapid results, Equipment-free and 
Delivered. Based on this definition an ideal POC would bring the test to the patient in an 
expedient and timely manner. Based on the WHO’s vision working with ideal POC requires 
little technical training or administrating or interpreting. In practice, very few POC diagnostics 
devices meet all of the ASSURED criteria[2], [16], [23]. Critical results (like positive drug 
resistant TB or CD4 t-cell counts of less than 200 in HIV infection) of some POC tests need to 
be confirmed by conventional laboratory tests. In addition, some POC platforms were designed 
for use in specific laboratory settings and take several hours to run the tests. In other words, 
they are hardly meet the “rapid” characteristic. However, in some cases, even the above-
mentioned devices have revolutionized the availability of rapid, accurate diagnosis of some 
serious diseases (especially drug-resistant TB) [24]. Some POC diagnostics, including HIV and 
CD4 rapid tests, are readily available and highly transportable. As an overall statistics, in 2013, 
58 million people were tested using HIV rapid tests [25]. 
From a technical point of view, although the POC devices are very effective, their full potential 
is limited to their connectivity features and the environment in which they are used. In order to 
extend the usefulness of POC devices, two important technical challenges need to be addressed: 
connectivity of devices and analytics of the machine-generated data. 
The connectivity of devices means the POC devices need to be connected to a communication 
infrastructure (wired or wireless network) in order to upload data to databases at both the local-
level (city, region or state) and the national-level. The connectivity allows control programs to 
monitor the quality of tests and testing, and optimize supply chain management; thus, 
increasing the efficiency of healthcare systems and improving patient outcomes [23]. 
Most hospitals and clinics rely on laboratories (external or internal) for test results. In other 
words, laboratories have the POC devices and the actual tests are run in laboratories after 
samples are received from clinics or hospitals. In most low and middle-income countries, there 
is no sufficient digital network infrastructure or regulations to send the results of tests back to 
the clinics and hospitals electronically. Apart from regulations, there must be an automatic 
mechanism to send the test result data back to clinics and hospitals in order to record test results 
along with patient data (local-level connectivity). Also, a centralized database should be hosted 
by Ministry of Health (MOH) or any appropriate national-level authority, and populated by the 
consolidation of all the databases in various healthcare settings (national-level connectivity). 
In this regard, the POC devices need to be able to be automatically connected to a reliable and 
secure communication network or there must be a consistent and regular procedure to record 
the results and send them via qualified personnel. 
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Although Access to mobile phone technology has rapidly expanded in low and middle-
income countries [26]–[29], most POC devices did not have the capability to connect to any 
communication network since connectivity was not considered as a priority at design time (or 
production time) of the devices. In this case, often the operator of the POC device needs to 
write down/copy-paste the results manually and then send them (directly or indirectly) to MOH 
(via mail or email or the internet, and so on). The manual procedure is error-prone and results 
in an increase in turnaround time (at local-level). This issue slows down analysis of the data at 
national-level as well since data at national-level are consolidated from all laboratories. This 
issue gets worse when portable POC devices are used. The closer POC diagnostic testing gets 
to the patient, the harder it becomes to consolidate data so that national-level authorities (like 
MOH) can analyze health outcomes countrywide [11], [30]. In addition, many laboratories are 
private and they just send data back to the hospitals and clinics. In other words, they do not 
send data to MOH. This is another issue at the national-level.    
If reliable connectivity of POC devices is implemented, the time of transmission of test results 
from laboratories to clinics as well as national-level authority (like MOH) can be considerably 
reduced, human errors are eliminated, and a centralized database of all historical test results 
can be created (at both local-level and national-level) therefore decisions can be made without 
waiting for the data to be transmitted (figure 1). 
 
Figure 1: Ideal flow of test results at local-level and national-level 
In the area of device connectivity, some companies have been working on the challenge of 
enhancing connectivity to encourage uptake of their diagnostics and to gain a larger share of 
the market. Recently data connectivity of POC devices has been changed from a “nice to have” 
feature to a “must have” feature in many cases. Some POC device manufacturers utilize built-
in modems to send data. Some other companies use external modems to connect the devices to 
the mobile communication network. A few companies use the above-mentioned method to 
send data to a central database which is deployed in the cloud. Using cloud-based storage has 
many technical as well as cost advantages over traditional on-premises storage approaches. 
Providing data connectivity is usually the responsibility of device manufacturers. However, 
providing the communication infrastructure is the responsibility of customers. Technology 
push and demand pull suggests that all POC devices will have data connectivity features in the 
near future. However, the issue with communication infrastructure, especially in low and 
middle-income countries, persists. 
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The second issue, which is highly dependent on the first issue, is that of data analytics. The 
primary purpose of POC devices is to generate data about test results. The test result data items 
coupled with patient demographic data can be used to extract fine-grained surveillance 
information. In other words, the datasets composed of demographic data combined with test 
results can be used to get individual-level as well as population-level pictures of the health of 
patients. Such a picture forms the basis for the penetration and effectiveness of healthcare 
services and, therefore, efficiency of policies in the area of healthcare as well. In addition, by 
combining the above datasets with location data, mobility patterns (of humans, animals, and 
airflow that transmit diseases), trends in disease prevalence can be extracted and utilized for 
prediction, which is highly valuable for decision making.  
In summary, availability of data (as a result of reliable connectivity, regulations, and policies) 
and data analytics are needed in order to support data-driven decision making which is the key 
procedure for monitoring and management of diseases and mitigation in case of diseases 
outbreaks.  
In order to address the device connectivity requirement, some regulations need to: a) be 
proposed and introduced by national and international authorities, b) some technical 
specifications/standards need to be implemented by device manufacturers, and c) suitable 
network infrastructures need to be deployed by all healthcare settings. From the above 
requirements, each country is responsible for providing the network infrastructure. In low and 
middle-income countries providing the network infrastructure is an important problem. The 
proposed solution of this paper illustrates utilizing a variety of connectivity approaches to make 
IoT-enabled POC in order to resolve the connectivity issue when there is no local-level and/or 
national-level connectivity.    
To address the data analytics challenge, cutting-edge big data technologies, which can manage 
and analyze the huge amount of data in batch (analysis on historical data) and real-time should 
be utilized. These technologies need an architecture with scalability, reliability, performance 
and fault tolerance characteristics. The implementation of the architecture using big data 
technologies provides the analytics infrastructure for large-scale management and analysis of 
data from multiple sources. In this case, POC devices can be considered as a data sources. 
However, access to data is a major challenge with a non-technical origin. The solution proposed 
by this paper shows how to provide the analytics infrastructure using state of the art big data 
architecture to get the most out of accessible data. 
4 Data Generated by POC and Accessibility Issue 
Combining the test results data (generated by POC) with patient demographic data results in 
comprehensive datasets. These comprehensive datasets can be used efficiently to extract fine-
grained surveillance information about many diseases via data analytics at individual-level as 
well as at population-level. From a technical point of view in order to use all individual-level 
data analytics procedures, the datasets need to be available, usable and accessible. The 
comprehensive datasets are definitely valuable for extracting surveillance information, but they 
are only partially available and unfortunately are not accessible in most cases. The 
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comprehensive datasets in most cases can be collected from different sources. Most of the time 
data is stored in digital formats so it is possible to create a digital repository of the datasets and 
make them available. As it described in the previous section, eventually all POC devices will 
have data connectivity features and local-level and national-level connectivity will be in place 
in near future, even in low and middle-income countries if the network infrastructure is in place. 
However, there are some serious issues in accessibility of the above-mentioned datasets. The 
comprehensive datasets are highly sensitive and have privacy-related issues. Because of myriad 
political, social, privacy and security issues, accessing individual-level data is very difficult (if 
not impossible). If demographic data are decoupled from test results, neither individual-level 
nor population-level information can be inferred from the test results. In other words, test 
results without patient demographic data lose their contexts and their use is limited to summary 
statistics (calculating count, average, minimum and maximum, for example) which has almost 
no value. Accessibility issue of comprehensive datasets is the most important barrier in front 
of extracting individual-level as well as population-level surveillance information. 
Unfortunately, the major reasons for accessibility issue are not technical and, in most countries, 
there is no feasible solution for this issue.  
5 Proposed Solution 
The POC devices are basically sensors and each sensor can generate large amounts of data 
during its intended measurement. In the case of POC devices, during the processing of a test 
sample, the devices generate lots of data which can be used to contextualize test results [31]. 
In this case, it is impossible to extract individual-level surveillance information. In other words, 
since the test results always contain identifiers (test identifiers), in theory, it is possible to join 
the test results with demographic data (using a patient identifier) to compile a comprehensive 
dataset even from POC deployment site. However, in practice, because of issues of 
accessibility of demographic data (due to its sensitive nature and potential patient identification 
risks), it is nearly impossible to link the test results to demographic data to generate a 
comprehensive dataset especially in low and middle-income countries. The lack of access to 
the comprehensive dataset is a major issue for extracting insights, especially at the individual 
level. POC generated data generally lack patient identifier data.  
However, this lack of patient identification can be seen as an advantage at the population-level 
since it facilitates (or almost fully removes) getting ethical approvals at various hierarchical 
healthcare settings. In other words, while this is a major issue for extracting individual-level 
information, the POC generated data still can be used for extraction of useful population-level 
insights. 
Since there is no need to get involved in working with highly sensitive data (patient 
demographic data), the population-level information can be extracted efficiently and quickly 
and, most of the time, without the need for approval of multiple ethics committees at different 
levels. This approach is a novel feature of the research described in this paper, and, to the best 
of the authors’ knowledge, no other research project has been done with this feature. Using just 
data generated by POC devices (including test result and machine-generated data like, for 
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example, the duration of the test, the location of the device, errors and warnings and quality 
control parameters) it is possible to get population-level surveillance information without using 
sensitive data. In other words, the contribution of the solution of this research paper is a new 
type of knowledge extraction based on just POC machine generated data using big data 
analytics. A very important element of this type of knowledge extraction is that the POC 
machine generated data would never be identifiable, thereby protecting the rights and the 
anonymity of the individual, whilst still allowing for vital population-level evidence to be 
obtained.  
In order to implement the proposed solution, data from various types of POC devices need to 
be managed and processed using a common data structure. Moreover, the solution needs to be 
able to run certain types of analytics and be extensible for future analytical needs. The common 
data structure and data analytics influence design and implementation of the system for the 
proposed solution. The following sub-sections explain the common data structure and analytics 
in more detail. 
5.1 Common Data Structure of the Proposed Solution 
The POC machine generated data are composed of a large set of data items about status and 
condition of the device during the test, and the result of the test, and the result of automatic 
quality control procedures during the test. Each type of device generates data in different 
structures, encoding, and formats. In this case, storage, management, and analysis of such POC 
machine generated data need a common data structure. The common data structure provides 
the unique model for mapping of different data structure and formats of various POC devices 
to a single semantic model.  
For this research, a common data structure was designed for POC devices that record 
CD4 t-cell counts. In this case, a single unit of observation contains a hierarchy of data 
about the test (time, date, id, type of test, measurement of t-cell count), device (type, make, 
unique identifier and geographic location), quality control of the test (errors and 
warnings during test), consumables for the device (cartridge unique identifier) and 
operator of the device. The following figure shows a single unit of observation for a 
hypothetical test on a POC diagnostics device (for CD4 t-cell counts-HIV test).  
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Figure 2: Hierarchical data structure of a single unit of observation for t-cell count test (HIV-related 
immune system test) 
5.2 Data Analytics in the Proposed Solution 
In general, there are four categories of analytics: descriptive, diagnostics, predictive and 
prescriptive [32]–[34].  
Descriptive analytics is used to explain what was/is happening in a given situation. This class 
of analytics can be used to answer questions such as how many tests are done each day, week, 
month or in real-time. How many tests has a certain POC device run in weekdays? How many 
types of errors occur? What are the most dominant error types? What are the trends in test 
results in certain POC device? 
Diagnostic analytics helps in understanding why certain things happened and what are the key 
drivers. For example, a national health authority could use this type of analytics to answer 
questions such as why a certain type of POC error is increasing. Why a specific device is not 
working at its highest potential, or why all test results showing CD4 <500 are coming from a 
single device. 
Predictive analytics helps to predict the future based on current and past situations (historical 
data). It is used to predict the probability of an uncertain outcome. For example, it can help to 
answer the following questions: what would be the growth/decay rate of the number of HIV-
positive patients based on recent trends? How many tests are going to be done in next 2 months 
(for preventing cartridge stock out)? Where are additional resources (such as cartridges, 
devices, operators, etc.) needed for next 6 months?  
The prescriptive analysis will suggest the best course of action to take to optimize the outcomes. 
Typically, prescriptive analysis combines a predictive model with domain specific rules. For 
example, it can suggest the best location for deploying a mobile POC devices based on existing 
POC devices, their capacities, population and spatial connectivity between POC devices (road 
network). 
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From analytics point of view, a system for analysis of the POC generated data requires specific 
considerations and solutions in order to implement all four types of analytics. In general, the 
system needs to be able to manage and analyze data in two different modes: batch mode and 
real-time mode. In this research, an architecture for management and analysis of POC 
generated data was designed based on best practices in big data system architecture and 
implemented via a combination of several big data technologies in a cloud environment. 
6 Big Data Architecture of the Proposed Solution 
Big data is defined as high volume, high velocity, and/or high variety information assets that 
require new forms of processing to enable enhanced decision making, insight discovery and 
processes optimization [34], [35]. This definition focuses not only on the characteristics of data 
but also on the way that the data are processed [36]. In fact, the scale of the data, flexibility in 
the integration of data from different sources and the distributed storage and processing of data 
in real-time are the main driving forces for the big data analytics technologies [36], [37].  
Management and analysis of the POC generated data require specific considerations and 
solutions. In general, the system needs to be able to manage different forms and analyze a large 
volume of data in two different modes: batch mode and real-time mode.  
Batch processing is used for getting a holistic view of a complex system which means the 
processing occurs after almost all the data items ingested into the system in a specified 
time. Batch processing is often complex and because of this it usually takes a long time to 
complete (few minutes to several days)[38]. In contrast, in real-time mode, the processing 
and output generation of data is continuously done as soon as new data items are ingested 
into the system[39]. Commonly real-time processing uses a window of time (or time limit) 
for processing of the most recent ingested data in the system[40]. Usually the time window 
is a few minutes, or less. The main difference between batch and real-time processing is 
determined by the time of analysis of data. If the analysis of data is done long after the 
events occurs it is batch mode. In contrast, when the analysis of data occurs at almost the 
same time that events happen, it is a real-time mode [41].   
In the context of this research, there are many situations that a full historical dataset of all POC 
devices is needed to be accessed in order to process data. Processing of full data always takes 
a long time. In this case, processing of data needs to be done in batch mode. For example, in 
order to perform statistical tests, predictive analytics and producing pivot reports, analysis of 
data need to be done in batch mode. As another example training predictive analytics 
models and evaluation of their performance almost always needs batch processing (use 
of historical data). In addition, for providing data to other systems like Geographical 
Information Systems (GIS) data need to be provided in batch mode.  
On the other hand, time sensitive applications and sensor-based monitoring applications 
need real-time processing of data [42]. For example, anomaly detection or event detection 
need a continuous evaluation of input data items against some criteria. Because of this, in 
the real-time processing, there is no need to access a large portion of historical data, but 
rather a small number of the most recent data inputs (table 1). 
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Table 1: summary of purpose, data size, and type of analytics of batch and real-time processing 
 Batch Processing Real-time Processing 
Main Purpose 
Processing/Analysing of all 
or large part of data 
Processing/Analysing of most 
recent ingested data  
Size of Data 
Large batches of data Individual records of data or 
micro-batches (a few 
records) 
Latency 
High (minutes to hours) Low (milliseconds to few 
minutes) 
Analytics 
Complex Analytics 
(simulations and modeling,  
advanced machine learning, 
predictive analytics, 
statistical learning, etc.) 
Simple and Complex 
Analytics (simple statistics 
like aggregate functions, 
descriptive analytics, 
anomaly detection, etc.).  
 
Designing systems capable of handling both batch and real-time processing is a complex 
task and requires an effective conceptual architecture for implementing the system. As 
an example, to achieve real-time processing capability a system must be able to perform 
message processing without having a costly (computationally) storage operation in the 
critical processing path. In this case, the system must have the capability to distribute 
processing across multiple machines to achieve scalability [42]. Fortunately, with help of 
several big data technologies, it is possible to design and implement a system architecture 
that can handle batch as well as real-time processing in a unified way. One such 
conceptual architecture is lambda architecture. 
Figure 3 shows an architecture based on lambda architecture[43], [44] that has been 
customized and extended for the purpose of this research. Lambda architecture is a 
conceptual, generic, scalable, and fault-tolerant data processing architecture based on 
distributed systems [36]. Lambda architecture is designed to handle massive quantities 
of data by taking advantage of both batch and stream processing [45].  
 
 
 
 
 
 
 
Figure 3: Big Data Architecture of the Proposed Solution 
As is illustrated in Figure 3, in the above architecture data from various types of POC 
devices ingested into the system in two paths for two types of processing. There are three 
Data from POC  
Master Dataset 
Process Stream 
Increment  
Views 
Real-time 
Batch 
Batch Views 
Real-time Views 
Real-time  
Increments 
Query and 
merge 
Output 
Speed Layer 
Batch Layer 
Service Layer 
Index 
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layers in the architecture; batch, speed, and service. The batch and speed layers are 
responsible for performing batch processing and real-time processing respectively, and 
service layer provides access to data in either/both paths. 
The batch layer is composed of a distributed append-only data storage system that stores 
data as time-stamped data items (master dataset in Figure 3). The master dataset 
intentionally does not support update or delete operations, meaning that all the data in 
the master dataset have a time identifier and new data do not override the existing data.  
Based on most common types of analytics, the batch layer pre-computes batch views on the 
master dataset regularly in specified times. These batch views provide a high latency 
representation of whole data. Computations for building batch views usually are written like 
single-threaded programs, and because of this can be automatically parallelized across a cluster 
of machines. This implicit parallelization makes batch layer computations scale to datasets of 
virtually any size.  
Same data ingested into the batch layer is also inserted temporarily in speed layer which is 
responsible for the real-time processing of data. Then, after a specific window of time, new 
data items replace the previously processed data which means only the most recent data is 
stored in the speed layer. The speed layer generates real-time views using real-time streaming 
data. In contrast to batch layer, the speed layer provides a real-time view of the ingested data. 
The major difference between batch and speed layer is that, in order to achieve the lowest 
possible latencies, the speed layer does not look at all the new data at once. Instead, it updates 
the real-time view as it receives new data instead of re-computing them like the batch layer 
does. 
The service layer has the ability to query (access) either historical and real-time data for 
performing analytics, or to provide data to external analytical software. More 
importantly, when access to all data including historical and real-time data are needed, 
the service layer can merge data from batch and speed layers and provide the most 
complete and most recent data for analytics purposes.  
For implementing the designed architecture, each POC device needs to send full generated data 
to a cloud infrastructure (Microsoft Azure) as messages. As mentioned before, many types of 
POC devices are not designed with this capability. Therefore, in order to resolve the 
connectivity issue, we used a few different methods.  
In the first method, we developed a software capable of reading low-level details from the 
devices. Then the software could send the data messages to the cloud platform using USB 
modems and pre-paid sim cards with the help of regional mobile communication network (as 
SMS messages). We utilized this method for 65% of the devices. For remaining 35% devices, 
we used network port of the POC devices (second method). The network port is usually 
utilized for sending the results of tests to a central computer (hub) for printing or sending 
the reports to the clinics or hospitals. In this research, we implemented a rather complex 
software background service called Resilient Queue System (RQS) to send the data over 
Internet to the cloud. The reason for the design and implementation of the RQS was 
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unreliability of Internet in almost 35% of devices. In other words, during the time that 
the devices work, the Internet was available for only a few hours (partially connected 
situation). Therefore, it was not possible to use the first method and send the test results 
as the tests happen. We implemtened the RQS to ensure that all the data were received 
successfully in the cloud. In the RQS, results of tests are stored temporally as messages in 
a resilient queue, until the Internet connection becomes available. The system then sends 
the messages one-by-one (in a first in, first out manner). Sending messages does not stop 
until the network disconnects from the Internet.  
On the cloud side, we implemented a service to receive messages and send an acknowledgment 
code to the RQS. As soon as the RQS gets the acknowledgment code, it removes (deletes) the 
message from the queue.  
The above architecture was implemented using HDInsight family of technologies 
including Apache Strom, Hive, and HBase inside Microsoft Azure cloud computing 
platform (Figure 4). The HDInsight is Microsoft’s managed implementation of Hadoop 
ecosystem [46]. The HDInsight can run on server versions of Linux and Windows. In this 
research, the system utilizes Windows Server at the Operating System level. 
Data ingestion is done in the system using an ASP.NET Web API layer. Then for the batch 
layer, HDInsight storage service was used to store the data (using Azure blob storage) and 
Apache Hive was utilized to create and update batch views. Apache Storm was deployed for 
generating real-time views in the service layer and Apache HBase was used in the service layer. 
Finally, for end users, a dashboard for different batch and real-time metrics was created using 
the PowerBI. Also for other software that solicit data from the system, APIs were provided 
using ASP.NET Web API.  
In addition to the dashboard, all data in the system is accessible to external analytical clients 
like R (for performing statistical analysis), Python (for performing machine learning) and 
ArcGIS (for performing spatial analysis). In section 10, the dashboards, results of a machine 
learning model for anomaly detection, and a spatial analysis for finding optimal location of a 
new mobile lab are illustrated.  
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Figure 4: Implementation of proposed solution 
7 Benefits of the method for research communities, health authorities, and 
device manufacturers 
The proposed method provides the ability to perform all types of analytics (descriptive, 
diagnostics, predictive and prescriptive) using just POC generated data (unidentifiable 
data) to extract useful information and insights potentially for three groups; researchers, 
healthcare settings, and device manufacturers.   
To the best of authors' knowledge the current paper is the first research paper about 
using just POC machine generated data for scientific purposes. Identification of trends 
in the distribution of diseases, evaluation of influential factors in disease spread, pinpoint 
the high-risk areas and population (for fine-grained confirmatory analysis) are a few 
examples of opportunities for research communities.  
For device manufacturers, POC machine generated data sometimes have been used for 
monitoring the operational status and performance of devices (from quality control 
perspectives). However, POC generated data hardly ever have been utilized for other 
useful applications such as modernizing supply chain management, planning the required 
equipment and consumables, and predictive (or preventive) maintenance of devices. 
For healthcare settings (labs, clinics, hospitals as well as national authorities) the method 
can be utilized for improving internal workflow (such as monitoring the performance of 
lab facilities and device operators), eliminating latency in availability and visibility of test 
results, providing quality control visibility of all settings, preventing stock-outs (of 
cartridges for example), optimizing usage of the devices, dynamic resource allocation 
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(finding best locations for deploying mobile labs), and enabling further health-related 
analysis of data.   
From the implementation point of view, the system has been designed in a way that can 
handle a huge amount of data from different data sources in both batch and real-time modes. 
Since the system is deployed to the cloud, there is no need for the establishment of highly 
expensive data centers or buying expensive servers. The fact that the cloud provider company 
(Microsoft inc. in the case of this research) is responsible for providing security, availability, 
recovery, and maintenance of the system is also a benefit. The horizontal scalability is done 
automatically by the cloud provider (this is called an elastic computing cloud). The horizontal 
scalability is one of the advantages of the modern architecture of the implementation of the 
method proposed in this research over conventional healthcare data management and analysis 
systems. In general, most conventional data analysis techniques are not suitable for working 
with huge amounts of data from different sources and with various data structures. However, 
as illustrated in the paper, careful design and implementation of the system enable benefiting 
from all advantages of the cloud. 
In addition, the implemented system can deliver data to external analytical software for 
further analysis. For example, it is very easy to connect to the system and get data in 
environments such as R and Python (for statistical learning and machine learning), 
ArcGIS (for spatial analysis and geostatistics), and Tableau (for visual analytics). The 
following section provides a broad range of analytics using the POC generated data for 
three above mentioned categories. 
8 The implemented Data Analytics and Dashboards 
For testing the functionality of the implemented system data from more than 2000 POC, 
devices in 3 countries in Africa ingested in the system (all from 2012-2014). The Data were 
gathered from national health authorities in those countries, African Health Observatory 
(AHO), The Global Health Network, device manufacturers and private companies (a few 
private consultancy companies like, for example, Alere and Cepheid), and WHO. Also, a 
large amount of simulated data were continuously generated and ingested in the system to test 
the real-time and batch processing capabilities and analytics of the system. Several types of 
data analytics were implemented.  
Table 2, shows details of data input, and data analysis in the implemented system. Since data 
records of the POC machine data are stored and analyzed as events (time-series observations), 
the table contains two categories of analytics that cover the full spectrum of analytics; temporal 
and spatio-temporal. The main difference between the two types of analysis is that in spatio-
temporal data analysis, location (position) and spatial relationships (like distance, direction, 
and connectivity between locations of the devices) were used for grouping and clustering the 
data whereas in temporal data analysis time of the test is mostly used for that purpose.  
Table 2: Implemented Analytics on POC generated machine data 
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Type Data Input Analytics 
Temporal  
Historical and Real-
Time information for 
all sites, group of sites 
and individual sites 
total successful tests, total errors, average tests per month 
(week, day and hour), average successful tests, tests 
statistics, error rate, top error types, the total number of 
operators, relationships among errors and number of tests 
through different types of regressions 
Health-Related 
Measurements and 
Metrics 
Percentage of patients with CD4 <200 (some important 
values for CD4 are 500, 350 and 200), real-time 
monitoring of sites with average CD4<500 or monitoring 
sites which has large number of patients with CD4 < 350, 
Number of tests with CD4 <200 in order to estimate the 
needed resources for ART (Antiretroviral Therapy), 
providing personalized advice after tests (if a 
professional was available and results were ready). 
Stock Information 
 
Report of daily consumption of resources (for each device 
or site), current stock value (for each site), total stock 
used, estimated daily consumption, estimated stock out 
date for each site, the prediction of consumption of 
cartridges for next two months, efficient allocation of 
cartridges (transporting cartridges from sites with 
low demand to sites with high demand), warning and 
alert long before stock out.  
Operator-related 
Information 
Real-time performance monitoring of operators, 
determining most and least precise operators for 
retraining purposes (with errors that are related to the 
operator like expiry date of cartridges). 
Spatio-
Temporal  
Location, population, 
mobility, connectivity 
of devices (by 
transportation 
networks) 
Spatial distribution of sites, service area determination of 
sites, and optimized resource allocation for finding the 
best place to deploy mobile clinics (based on location, 
distance, population and existing transportation network). 
 
The result of above analytics in the implemented system is a set of interactive dashboards. 
There are three main dashboards (Healthcare Settings, Test Analytics, Errors and 
Warnings) in the system. Each dashboard consists of a set of interactive panels of 
visualizations and reports. The following illustrations display separate visualizations and 
reports of some of the dashboards, and describe how some useful information can be 
extracted based on the POC generated data. Figures 5 and 6, illustrate parts of “Test 
Analytics” and “Healthcare Settings” dashboards respectively.  
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Figure 5: Part of Test Analytics dashboard. Two left panels show the count of tests with CD4 < 200 and 
CD4 < 500. On right panels, devices with highest number of results with CD4 < 200 and CD4 < 500 are 
shown (each device has a location). 
 
Figure 6: Part of Healthcare Setting dashboard. The two left panels illustarate the count of tests and 
successful tests in different healthcare settings. Hovering mouse over the pie chart shows the count and 
percentage of the tests grouped by healthcare setting type. 
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Figure 6 show some information about successful and failed tests in different healthcare 
settings. More than half of tests (54.7%) had been done in labs and about 27.3% and 18% were 
performed at hospitals and mobile labs respectively. Based on Figure 7, in spite of the fact that 
a number of tests in labs are almost three times more than the number of tests in mobile labs, 
the percentage of failed tests in mobile labs is more than labs and hospitals as well. This 
interesting observation can be seen as the red line in Figure 7. This line can be interpreted as a 
result of one or combinations of following reasons: 1) Non-uniform allocation of human 
resources e.g. relatively inexperienced operators in mobile labs, 2) Allocation of faulty devices 
to mobile labs (or any problem associated with transportation of devices) and 3) Existence of 
a serious maintenance issue due to environment; for example, maintaining cartridges in 
environments with more than 40 degree centigrade for devices or test sample in mobile lab 
settings.
 
Figure 7: Total Tests (blue bars), Failed Tests (yellow bars) and Failed Tests Percentage (red line) for 
each Site Type  
Figure 8, illustrates the monthly trend of tests (successful tests per months for all sites) in 2014. 
January to February, August to September and November to December show decreases. 
Similarly, February to March, June to July and September to October show increases in tests. 
These trends might have occurred randomly, or because of cultural, social or environmental 
factors. Further studies need to be done for any causal statements about this observation.  
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Figure 8: Trend of Number of tests per months for 2014  
Figure 9 represents the monthly trends of tests based on site type. As illustrated in the figure, 
unlike the general monthly trend of Figure 8, in mobile labs the number of tests increased 
during April to May, and the November to December periods. 
 
 
Figure 9: Trend of Number of tests per months for 2012 for each Site Type 
The monthly trends (Figure 8, 9) for different years, can be compared and general anomalies 
can be detected. Further research and observations are needed in order to determine reasons  
for the causality of the anomalies. However, this can be seen as an advantage of the method 
proposed in this paper, especially in real-time data collection. It is possible to extract norms of 
the data in different seasons based on historical data and then using some rules for anomaly 
detection or using artificial intelligence techniques for the system to learn from data. The 
system then is capable of detecting anomalies automatically without the need for human 
interaction. This anomaly detection can be done in real-time. In this case, the system can take 
appropriate actions by using alerts or triggers, for example, by broadcasting an email to 
responsible people to make them aware of the current situation. In other words, the value 
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remains in that these anomalies could be determined in real time and not require the delay that 
validation of traditional surveillance methods usually entails. In addition, these anomalies can 
result in automatic actions (like an alert, or in more serious situations shutting down of the 
device). 
Figure 10 shows the pie chart for errors. As is illustrated in the figure, human error (errors 
related to the manual tasks of operators) accounts for 77% percent of all errors. In other words, 
using expired cartridges (cartridge expiry) and putting the inadequate amount of blood in the 
cartridge (volume errors) account for 77% of all errors. This is a highly valuable observation 
since it means operators may need more training about using and maintaining the devices and 
cartridges in appropriate conditions. At the other hand, this important observation means with 
relevant actions (like more training) it is possible to eliminate about 77% of total errors. Again, 
the effectiveness of relevant actions can be monitored in real-time, with the impact on the 
quality of tests being observed immediately. 
 
Figure 10: Major Error Types  
As it stated above, the mentioned valuable observation about error types might be because of 
some maintenance issues. For example, the POC devices and their cartridges have to be 
maintained and used in a certain range of temperature (2-30 centigrade) or humidity (10%-
75%). With further investigations about weather condition from multiple sources, just 12% of 
measurements were done outside of the temperature and humidity range. Therefore, 
oversimplifying of the maintenance and usage procedures of POC devices might be the cause 
of this error. This might lead us to another interesting fact. International health organizations 
like CDC and WHO tend to oversimplify the usage and maintenance procedures of various 
POC devices in resource-limited settings. This can be seen in the following quote “The 
characteristic of the Pima CD4 assay indicates that it is ideal for a point-of-care or resource-
limited setting.  The assay requires minimal training and technical skill with no sample 
processing manages results and reports on the analyzer, and does not require maintenance, 
cold-chain storage, or ancillary equipment.”[47]. Although enthusiasm and hope are increasing 
around POC diagnostics for diseases of global health importance, a deeper appreciation of 
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likely barriers in each healthcare setting and operations (for example lack of training) might 
help test developers and public health managers to identify the complexities of using POC [48]. 
Figure 11 shows the monthly trends of errors. This reveals a remarkable observation; the errors 
seem to be based on repeating patterns in every successive two or three months. This might be 
due to the pattern of the inspection procedure every successive two or three months. As another 
observation, before the new years’ holidays, error rates increase while after holidays error rates 
decrease. This can be hypothesized as most of the experienced operators tend to go to new 
years’ holidays before the New Year eve. These kinds of patterns can be identified and detected 
by defining rules or inferring patterns in the system. Using the mentioned rules or patterns, the 
system can identify similar trends automatically in real-time and then inform the responsible 
people (via email for example) in order to take appropriate actions. 
 
 
Figure 11: Error Rate per months  
Treatment guidelines generally recommend that HIV-infected patients with a CD4 cell count 
less than 350 should receive highly active antiretroviral therapy (HAART) [16]. Figure 12 
shows that mobile labs have the most of the tests with CD4 less than 350. This information can 
be used for identification of population or areas at high risk, or to allocate more resources (in 
this case enough HAART therapy or HAART therapy adherence support) to those sites. 
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Figure 12: CD4 < 350 grouped by site type per month  
It is possible also to create similar reports for other amounts of CD4 for different purposes. It 
is also easy to calculate simple statistics for any numeric or categorical variable in the dataset. 
Figure 12, shows the descriptive statistics for CD4 variable. As it is shown, the amount of CD4 
in 25% of all tests are less than 218 (First Quartile). 
 
Figure 13: Summary Statistics for CD4 (25% of test results are below 218, 25% are more than 644) 
As it described before, these reports can be used effectively to identify high-risk areas and 
population. Figure 14 illustrates the top 10 devices (and therefore sites) with the highest number 
of CD4 less than 500. Finding the location of the devices is an easy task since the location is 
part of stored data in the common data structure. 
 
 
 
 
 
 
Figure 14: Devices with the highest number of CD4 <500 
Figure 15 shows operator ID codes of those who made lowest mistakes (defined as failed tests 
due to human error). The similar report could show the operator ID and related sites which 
made the highest number of failed tests. The latter report can be used for providing more 
training or frequent inspection (or unannounced inspections). 
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Figure 15: Top 10 Most Precise Operators 
Figure 16 shows ten devices with the highest number of tests. This report can be used for 
regular checks and overhaul maintenance planning of the devices. Also, the similar report can 
show which devices are mostly idle. The advanced type of analytics (optimization) can use the 
mentioned report for producing a plan for allocation of idle devices or consumables to the sites 
which need more capacity.  
 
 
 
  
 
Figure 16: Top 10 Most Used Devices (regular checks is more needed than other devices) 
The location of devices is an important data item in the common data structure. The locations 
of devices can mostly be considered as the location of hospitals and labs for which the tests are 
done. This assumption can be automatically controlled with the IP (Internet Protocol) address 
of the network (via geolocation API of HTML5). For mobile labs (and the devices with sim 
modems), there are several techniques for determining the location of the devices. Generally 
using cell towers location in a communication network and techniques like triangulation are 
precise enough to calculate the location of mobile labs automatically. A good example of 
prescriptive analytics is to find the most suitable location for a new mobile lab. For performing 
the site suitability analysis, population data of the country, road network, and location and 
capacity of existing labs were utilized as input to a complex spatial analysis model for 
determining a most suitable location in a GIS environment (figure 17). 
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Figure 16: Most suitable location for a new mobile lab  
(size of red symbols are proportional to capacity of sites) 
9 Conclusions and Future Work 
This research paper describes a novel approach for knowledge extraction for healthcare 
domain. Usually demographic data about each patient is needed for performing complex 
analytics. Unfortunately, because of a mixture of political, social, privacy, technical, and 
security issues, especially in low and middle-income countries, using demographic data 
at the individual level is very difficult (if not impossible). The contribution of the paper is 
the performance advanced analytics to extract valuable insights without using 
demographic data at the individual level. An important and unique aspect of this novel 
approach is the data are not individually identifiable so there is no concern about privacy. 
In this research, just device (POC) generated data has been used to extract valuable and 
useful information and insights at a population-level. The proposed method provides the 
ability to perform all types of analytics (descriptive, diagnostics, predictive and 
prescriptive) using just POC generated data (unidentifiable data) to extract useful 
information and insights potentially for researchers, healthcare settings, national and 
international health authorities, and device manufacturers. Identification of high-risk 
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areas and high-risk populations are two important results of applying the method 
described in the paper.  
Also, the paper describes the implementation of the method, using a large-scale and 
complex architecture using IoT-enabled POC devices and big data analytics. As 
illustrated in the paper, the implemented system can perform descriptive, diagnostic, 
predictive, and prescriptive analytics in batch and real-time modes.   
Combining POC machine data with other sources of data, especially volunteer content 
generation applications such as social microblogging (like Twitter), social networking (like 
Facebook), location-based services (like Foursquare), and volunteer geographic information 
(like OpenStreetMap) is a future direction for this research. With these data sources and by 
using cutting-edge methods from artificial intelligence and machine learning, a new set 
of analysis can be done on the data and therefore new insights can be extracted from 
different types of analytics.  
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